For Investors & Media

Alcon, Inc. develops, manufactures and markets surgical, pharmaceutical, and consumer vision care products. In the eye care industry, we have the broadest product portfolio and possess leading market share in most product categories.

With operations in 75 countries, products sold in more than 180 countries and sales of US$6.3 billion (2008) – Alcon is the largest, most profitable and specialized eye care company worldwide.

Our focus is clear – create value for our customers and our shareholders by raising the standard of eye care across the globe and building on our position as the largest eye care company in the world. Alcon has a reputation for bringing "best in class" products to market, as well as introducing new levels of treatment and expertise to areas that lack basic eye care. We continually work toward a day when preventable blindness and other treatable eye conditions are no longer a threat to the global community.

Founded more than 60 years ago by two pharmacists in Fort Worth, Texas, Alcon was wholly acquired by Nestlé, S.A. (the world's largest food company) in 1978. We completed a partial IPO in March 2002, and 25 percent of the company is now traded on the New York Stock Exchange (NYSE) under the ticker symbol ACL.

Alcon At-a-Glance

Discover Alcon's company details.

Online Press Room

Browse resources for news media, including press kits and images.

Press Releases

Read current and past press releases.

Financials

Access our annual reports, SEC filings, and additional company information.

Calendar of Events

Find out about upcoming scheduled events.

Webcasts & Presentations

Hear what we have to say on a number of topics.

Corporate Governance

Understand our focus on integrity and ethics.

Investor & Media Frequently Asked Questions

Discover the answers to many of your questions.

Investor & Media Contacts

Tell us if we can help with more information.

back to top